<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative predictive values of the BD FACSPresto CD4+ T cell technology used in the laboratory compared with the BD FACSCalibur across three CD4+ T cell thresholds.</p
<p>Number of CD4+ T cell test results by technology and CD4+ T cell threshold used.</p
Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART...
<p>Sensitivity (A) and Specificity (B) for stimulation without mitomycin; (C) and (D) for stimulatio...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity and specificity of the BD FACSCount compared with the BD FACSCalibur across three CD4...
<p>Sensitivity, Specificity, Positive (PPV) and Negative Predictive values (NPV) and misclassificati...
<p>Two-by-two table of the BD FACSPresto compared with FACSCount using a CD4 threshold of 500 cells ...
Estimation of bias of Muse Auto CD4/CD4% System at different clinically relevant CD4 T cell threshol...
<p>(A) Representative overlay flow cytometry dot/density plots of TB-, PPD- and mitogen (mito)- spec...
Precision of CD4 T cells counts and percentages at different categories of CD4 T cells/μL.</p
<p>Bland-Altman comparisons between the BD FACSPresto™ with capillary blood (a-c) and venous blood (...
<p>(A) The magnitude of antigen-specific CD4 T cells expressing any of the 3 cytokines measured (i.e...
Sensitivity, specificity, and positive and negative predictive values of the three methods using sto...
<p>Number of CD4+ T cell test results by technology and CD4+ T cell threshold used.</p
Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART...
<p>Sensitivity (A) and Specificity (B) for stimulation without mitomycin; (C) and (D) for stimulatio...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity, specificity, upward and downward misclassification rates, and positive and negative ...
<p>Sensitivity and specificity of the BD FACSCount compared with the BD FACSCalibur across three CD4...
<p>Sensitivity, Specificity, Positive (PPV) and Negative Predictive values (NPV) and misclassificati...
<p>Two-by-two table of the BD FACSPresto compared with FACSCount using a CD4 threshold of 500 cells ...
Estimation of bias of Muse Auto CD4/CD4% System at different clinically relevant CD4 T cell threshol...
<p>(A) Representative overlay flow cytometry dot/density plots of TB-, PPD- and mitogen (mito)- spec...
Precision of CD4 T cells counts and percentages at different categories of CD4 T cells/μL.</p
<p>Bland-Altman comparisons between the BD FACSPresto™ with capillary blood (a-c) and venous blood (...
<p>(A) The magnitude of antigen-specific CD4 T cells expressing any of the 3 cytokines measured (i.e...
Sensitivity, specificity, and positive and negative predictive values of the three methods using sto...
<p>Number of CD4+ T cell test results by technology and CD4+ T cell threshold used.</p
Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART...
<p>Sensitivity (A) and Specificity (B) for stimulation without mitomycin; (C) and (D) for stimulatio...